References
- Bonelli J., Hitzenberger G., Krause W., Wendt H., Speck G. Pharmacokinetics and pharmacodynamics of mepindolol sulphate. International Journal of Clinical Pharmacology, Therapeutics and Toxicology 1980; 18: 169–176
- Blood and Other Body Fluids, D. S. Dittmer. Fed. Am. Soc. Exp. Biol., Washington, DC
- Horowski R., Sastre M. Clinical effects of the neurotropic selective cAMP phosphodiesterase inhibitor rolipram in depressed patients: Global evaluation of the preliminary reports. Current Therapeutic Research 1985; 38: 23–29
- Krause W., KÜhne G. Pharmacokinetics of rolipram in the rhesus and cynomolgus monkeys, the rat and the rabbit. Studies on species differences. Xenobiotica 1988; 18(5)561–571
- Laemmel K., Sastre M. Rolipram as an antidepressant, Abstract, VII. Proceedings, World Congress of Psychiatry. Vienna 1983; 677
- Poland H., Woloszczak R. A program library for computing the parameters of linear compartment models in pharmacokinetics. International Journal of Bio‐Medical Computing 1980; 11: 115–128
- Przegalinski E., Bigajska K., Lewandowska A. The influence of rolipram in the central serotoninergic system. Pharmacopsyhiatria 1981; 14: 162–166
- Schnelle K., Garrett E. R. Pharmacokinetics of the β‐adrenergic blocker sotalol in dogs. Journal of Pharmacological Science 1973; 62(3)362–375
- Wachtel H. a, Selective adenosine cyclic 3′,5′‐monophosphate phosphodiesterase inhibitors—a novel class of antidepressant? Abstract. 13th Congress Colloquium International Neuropsycho‐pharmacology. Jerusalem 1982; 740
- Wachtel H. Characteristic behavioural alterations in rats induced by rolipram and other selective adenosine cyclic 3′,5′‐monophosphate phosphodiesterase inhibitors. Psychopharma‐cology 1982b; 77: 309–316
- Wachtel H. Potential antidepressant activity of rolipram and other selective cyclic adenosine 3′,5′‐monophosphate phosphodiesterase inhibitors. Neuropsychopharmacology 1983; 22: 267–272
- Zeller E., Stief H. J., Pflug B., Sastre Hernandez Y. Results of a phase II study of the antidepressant effect of rolipram. Pharmacopsychiatria 1984; 17: 188–190